Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 42,198 shares at $80.10 ($3.4M) on 2022-12-16, disclosed to the SEC on 2022-12-20.
Open-market sale of $3.4M KRYS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.10 | 10,527 | $843K | 24.9% |
| 2 | $80.10 | 10,527 | $843K | 24.9% |
| 3 | $80.10 | 10,572 | $847K | 25.1% |
| 4 | $80.10 | 10,572 | $847K | 25.1% |
| Total | $80.10 avg | 42,198 | $3.4M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |